CVS Group plc PDMR Dealing

RNS Number : 6558T

CVS Group plc

24 June 2024

 

24 June 2024

 

CVS Group plc

 

("CVS" or the "Company")

 

PDMR Dealing

CVS, one of the UK's leading providers of integrated veterinary services, announces that it was notified on 24 June 2024 that Joanne Shaw, Non-executive Director of the Company purchased a total of 959 ordinary shares of 0.2p each in the Company ("Ordinary Shares") on 20 June.

As a result, Joanne Shaw's total interest in the Company, including any persons closely associated, is now 1,548 Ordinary Shares, representing 0.002 per cent of the total voting rights of the Company.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Contacts:

CVS Group plc                                                                                                                                via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker)                                                 [phone]

Christopher Golden / James Steel / Andrew Clark / Lalit Bose

 

   Berenberg (Joint Broker)                                                                                          [phone]

Toby Flaux / Ben Wright / James Thompson / Milo Bonser

 

Camarco (Financial PR)                                                                                             

Geoffrey Pelham-Lane                                                                                [phone]

Ginny Pulbrook                                                                                                     [phone]

    

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Joanne Shaw
2	Reason for the notification
a)	Position/status	PDMR (Non-Executive Director)
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	CVS Group plc
b)	LEI	213800J41XDQ2NX48O05
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument   Identification code	Ordinary shares of 0.2 pence each     GB00B2863827
b)	Nature of the transaction	On-market purchase
c)	Price(s) and volume(s)	Price(s) - pence   Volume(s) 1,042.27 959
d)	Aggregated information   - Aggregated volume     - Price	N/A - single transaction
e)	Date of the transaction	20 June 2024
f)	Place of the transaction	London Stock Exchange - AIM (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHEZLFLZQLZBBD